Related Experiment Videos
Defects in the interferon-gamma and interleukin-12 pathways
Sergio D Rosenzweig1, Steven M Holland
1Division of Immunology, Department of Pediatrics, Hospital Nacional de Pediatría Juan P. Garrahan, Buenos Aires, Argentina.
Immunological Reviews
|January 22, 2005
Summary
The interferon-gamma (IFN-gamma)/interleukin-12 (IL-12) pathway is crucial for controlling mycobacterial infections. Understanding genetic mutations in this pathway offers diagnostic and therapeutic insights for immune disorders and cancer.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- The interferon-gamma (IFN-gamma)/interleukin-12 (IL-12) pathway is a critical component of the immune system.
- This pathway plays a central role in controlling mycobacterial infections.
Purpose of the Study:
- To review recent advances in understanding the IFN-gamma/IL-12 pathway.
- To analyze human mutations within this pathway and their link to mycobacterial disease susceptibility.
- To describe diagnostic and therapeutic strategies related to this pathway.
Main Methods:
- Analysis of human genetic mutations in key pathway components (IFN-gammaR1, IFN-gammaR2, IL-12p40, IL-12 receptor-beta1, STAT1, NEMO).
- Review of existing literature on the pathway's role in immunity, autoimmune diseases, and cancer.
- Examination of genotype-phenotype correlations.
Main Results:
- Human mutations in the IFN-gamma/IL-12 pathway confer genetic susceptibility to mycobacterial diseases.
- The pathway is vital for immune control against various challenges, as evidenced by animal models and human genetics.
- The pathway's involvement extends to autoimmune diseases and cancer pathogenesis and control.
Conclusions:
- The IFN-gamma/IL-12 pathway is fundamental for immune defense, particularly against mycobacteria.
- Genetic variations in this pathway have significant clinical implications for diagnosis and treatment.
- Understanding genotype-phenotype correlations offers therapeutic potential for immune-related conditions.